Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000006537
http://purl.bioontology.org/ontology/NDFRT/N0000006537
|
|---|---|
| Preferred Name | Neostigmine [Chemical/Ingredient] |
| Synonyms |
Proserine
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
Neostigmine
Synstigmin
Prozerin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
Proserine
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
Neostigmine
Synstigmin
Prozerin
|
|---|---|
| prefLabel | Neostigmine [Chemical/Ingredient]
|
| MESH DEFINITION | A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
|
| MESH DUI | D009388
|
| MESH UI | M0014615
|
| MeSH name | Neostigmine
|
| type | |
| tui |
T109
T121
|
| notation | N0000006537
|
| Semantic type UMLS property | |
| NUI | N0000006537
|
| Ingredient of | |
| cui | C0027679
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |